D69.8 coverage policies: Medicare and commercial payers

34 active Medicare policies list D69.8, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for D69.8

Free account. Policy pages stay open to everyone.

Medicare policies listing D69.8

LCD · NGS-J6-L37606

Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases

J6 · Effective Aug 1, 2018

LCD · NGS-JK-L37606

Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases

JK · Effective Aug 1, 2018

LCD · CGS-J15-L38070

MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies

J15 · Effective Feb 10, 2020

LCD · NORIDIAN-JE-L38123

MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies

JE · Effective May 17, 2020

LCD · NORIDIAN-JF-L38123

MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies

JF · Effective May 17, 2020

LCD · PALMETTO-JJ-L38047

MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies

JJ · Effective Feb 10, 2020

LCD · PALMETTO-JM-L38047

MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies

JM · Effective Feb 10, 2020

LCD · WPS-J5-L38176

MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies

J5 · Effective Feb 9, 2020

Commercial payer policies listing D69.8

1 policy from 1 payer

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Cigna

Cigna policies listing D69.8, with the code’s status in each
Policy	Effective	Status of D69.8
Flow CytometryPayerPolicy · CIGNA-0538	Sep 15, 2026	Covered